Early research (Phase 1)Ended earlyNCT03539731
What this trial is testing
[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
Who this might be right for
Healthy SubjectIntracranial NeoplasmGlioblastoma
Guido A. Davidzon, MD, SM 27